HSA — authorised 11 January 1984
- Marketing authorisation holder: PURDUE PHARM PRODS
- Status: likely_approved
HSA authorised Dilaudid-Hp on 11 January 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 11 January 1984.
PURDUE PHARM PRODS holds the Singaporean marketing authorisation.